Valuation : Grifols, S.A.

Market Cap 5.95B 6.91B 5.58B 5.1B 9.6B 660B 9.63B 66.22B 25.84B 333B 25.94B 25.37B 1,105B P/E 2026 *
12.7x
P/E 2027 * 9.7x
Enterprise Value 14.4B 16.71B 13.5B 12.32B 23.22B 1,597B 23.29B 160B 62.49B 806B 62.73B 61.37B 2,673B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.73x
Free-Float
79.65%
Yield 2026 *
2.77%
Yield 2027 * 3.02%
1 day-1.04%
1 week+0.38%
Current month-0.14%
1 month-0.38%
3 months+4.06%
6 months-6.40%
Current year-7.01%
1 week 9.8
Extreme 9.804
10.17
1 month 9.62
Extreme 9.622
10.6
Current year 8.43
Extreme 8.432
11.7
1 year 8.43
Extreme 8.432
12.87
3 years 6.36
Extreme 6.362
15.92
5 years 6.36
Extreme 6.362
22.64
10 years 6.36
Extreme 6.362
34.31
Manager TitleAgeSince
Chief Executive Officer 58 2024-03-31
Director of Finance/CFO 49 2024-09-15
Compliance Officer 54 2013-12-31
Director TitleAgeSince
Chairman 76 2010-01-24
Director/Board Member 70 2000-04-12
Director/Board Member 62 2015-05-23
Date Insider Type Main position Quantity % Market Cap.
2/26/26 Free

Director

7,679 0.0018%
2/26/26 Free

Director

1,408 0.0005%
2/18/26 Others

Director

1,408 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
-1.04%+0.38%-18.28%-23.28% 6.91B
-1.67%-4.78%+37.02%-4.42% 79.3B
-0.90%+2.39%-18.98%-35.69% 59.21B
-3.35%-4.92%+463.91%+21.22% 55.09B
-6.78%-4.19%-4.50%+28.86% 49.86B
-2.43%-2.35%+8.03%+163.45% 47.9B
-1.35%+0.79%+64.72%-17.56% 32.28B
-2.64%-2.69%+48.59%+91.84% 25.21B
-0.09%+4.98%+18.59%+209.35% 23.87B
-0.34%+1.35%+60.10%+122.64% 16.89B
Average -1.75%-1.04%+65.92%+55.64% 39.65B
Weighted average by Cap. -1.96%-2.00%+81.15%+41.94%

Financials

2026 *2027 *
Net sales 7.66B 8.88B 7.18B 6.55B 12.34B 849B 12.38B 85.16B 33.23B 429B 33.36B 32.63B 1,421B 8.13B 9.44B 7.63B 6.96B 13.12B 902B 13.16B 90.49B 35.31B 455B 35.44B 34.67B 1,510B
Net income 536M 622M 502M 458M 864M 59.41B 866M 5.96B 2.32B 29.99B 2.33B 2.28B 99.43B 699M 812M 656M 599M 1.13B 77.56B 1.13B 7.78B 3.04B 39.15B 3.05B 2.98B 130B
Net Debt 8.45B 9.8B 7.92B 7.23B 13.62B 937B 13.66B 93.94B 36.65B 473B 36.8B 36B 1,568B 8.1B 9.4B 7.6B 6.94B 13.07B 899B 13.11B 90.15B 35.17B 454B 35.31B 34.54B 1,504B
Logo Grifols, S.A.
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows: - products derived from plasma (86.2%): products for use by the pharmaceutical and biotechnology industries; - diagnostic machines and reagents (8.5%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers; - hospital products (2.1%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies; - other (3.2%): primarily intermediate biological products and subcontracted manufacturing services. Net sales are distributed geographically as follows: Spain (5.6%), European Union (15.9%), the United States and Canada (56.5%) and other (22%).
Employees
25,258
Date Price Change Volume
26-08-28 €9.950 -1.04% 979,824
26-08-27 €10.06 +0.20% 764,067
26-08-26 €10.04 -0.10% 951,980
26-08-25 €10.05 +1.67% 1,090,834
26-08-24 €9.880 -0.32% 908,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
9.950EUR
Average target price
14.76EUR
Spread / Average Target
+48.32%

Quarterly revenue - Rate of surprise